QUADRAMET er kontraindiceret: • overfølsomhed over for det aktive stof (ethylendiamintetramethylenphosphonat (EDTMP) eller lignende phosphonater) eller over for et eller flere af hjælpestofferne • til gravide kvinder (se pkt. 4. 6) • til patienter, som har modtaget kemoterapi eller ekstern halvkropsbestrålingsbehandling inden for 6 uger før.
QUADRAMET is contra-indicated: • Hypersensitivity to the active substance (ethylenediaminetetramethylenephosphonate (EDTMP) or similar phosphonates) or to any of the excipients. • in pregnant women (See section 4.6). • in patients having received chemotherapy or hemi-body external radiation therapy in a preceding period of 6 weeks.